| Schedule of Potentially Dilutive Securities |
The following table summarizes the Company’s potentially dilutive securities at September 30, 2026 and 2025: | | | | | | | | | | | | | As of September 30, | | 2026 | | 2025 | | Unvested restricted stock | 11,049,018 | | | 11,031,573 | | | Options | 4,024,156 | | | 4,362,316 | | | Warrants | — | | | 165,214 | | | Shares issuable upon note conversion | 23,977 | | | 21,973 | | | Stock Tracking Units | 41,625 | | | — | | | Total | 15,138,776 | | | 15,581,076 | |
|
| Schedule of Earnings Per Share, Basic and Diluted |
The computation of basic and diluted EPS is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended September 30, | | Nine months ended September 30, | | (in thousands, except share and per share data) | 2026 | | 2025 | | 2026 | | 2025 | | Net income | 55,463 | | | 390,895 | | | 83,021 | | | 424,142 | | | Weighted-average common shares outstanding | 140,786,274 | | | 145,416,901 | | | 142,318,594 | | | 146,273,554 | | | Dilutive effect of potential common shares | 15,138,776 | | | 15,581,076 | | | 15,422,660 | | | 15,828,819 | | | Weighted-average common shares outstanding assuming dilution | 155,925,050 | | | 160,997,977 | | | 157,741,254 | | | 162,102,373 | | | | | | | Net income per share - basic | 0.39 | | | 2.69 | | | 0.58 | | | 2.90 | | | Net income per share - diluted | 0.35 | | | 2.43 | | | 0.52 | | | 2.62 | |
|